The forecast for cervix uteri malignant neoplasms mortality in Canada from 2024 to 2028 shows a consistent increase, with the number of female deaths expected to rise from 430 in 2024 to 438 in 2028. As of 2023, the figure stood at 428. The year-on-year variation suggests a stable upward trend with each year experiencing a rise of approximately 0.46% annually. Over the last five years, the compound annual growth rate (CAGR) stands at 0.47%, indicating a modest but persistent increase in mortality rates.
Future trends to watch for include the impact of continued advancements in medical technology and cancer treatment, which could potentially slow down the mortality rate increase. Moreover, initiatives in preventative care, public health campaigns focusing on vaccination, and early detection practices might also influence future trends, potentially leading to a decrease in mortality rates over a longer period.
